Shentu vs Injective — how do they compare? Shentu trades at Rp1,842 (market cap Rp297,01M, Rp12,62M 24h volume), while Injective trades at Rp86,066 (market cap Rp8,6T, Rp1,3T 24h volume). The key difference: Injective is far larger — about 28955.3× Shentu's market cap, and Shentu's circulating supply is 161,4M CTK versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Shentu for 43 Days and Injective for 36 Days on average.
| CTK | INJ | |
|---|---|---|
Market Cap | Rp297,01M | Rp8,6T |
Volume (24h) | Rp12,62M | Rp1,3T |
Circulating Supply | 161,4M CTK | 100M INJ |
Typical Hold Time | 43 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Shentu (CTK) is trading at Rp1,837 with a market cap of Rp295.46 million, showing bearish technical signals from moving averages while oscillators remain neutral. The token faces resistance near Rp1,937 with support at Rp1,823. Hold time of 43 days suggests moderate holding patterns. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical pressure outweighing neutral momentum indicators. Key opportunity lies in potential bounce from support levels, while major risks include limited liquidity and the prevailing bearish trend. Investors should monitor for any protocol developments that could shift sentiment.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Shentu Chain, a security-first, delegated proof-of-stake blockchain, for trustworthy execution of mission-critical applications, including DeFi, NFTs, and autonomous vehicles. Shentu Chain prioritizes cross-chain compatibility, built as a Cosmos Hub with full EVM and Hyperledger Burrow compatibility, as well as compatibility with eWASM and Ant Financial’s AntChain.
Read more on CTK →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →